← Evidence map

ReviewLung Cancer (Auckland, N.Z.)2017

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy.

Mariacarmela Santarpia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

55 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28860885